How do I adjust insulin for a patient on 80 units of Lantus (insulin glargine) BID and a sliding scale Humalog (insulin lispro) with meals who is experiencing morning hypoglycemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Reduce the Evening Dose of Lantus to Address Morning Hypoglycemia

For a patient on 80 units of Lantus BID experiencing morning hypoglycemia, reduce the evening (bedtime) dose of Lantus by 10-20% (8-16 units) while maintaining the morning dose unchanged. 1

Understanding the Problem

Your patient is experiencing morning hypoglycemia, which indicates excessive basal insulin action overnight from the evening Lantus dose. This is a common issue with twice-daily basal insulin regimens where the evening dose peaks during the early morning hours. 2, 3

Specific Adjustment Strategy

Immediate Action

  • Reduce the evening Lantus dose by 10-20% (from 80 units to 64-72 units) 1
  • Keep the morning dose at 80 units unchanged initially 1
  • Monitor fasting blood glucose closely over the next 3-7 days 1

Titration Approach

  • If morning hypoglycemia persists after the initial reduction, decrease the evening dose by an additional 10-20% 1
  • If fasting glucose becomes too high (>130-150 mg/dL), increase the evening dose by 2 units every 3 days 1
  • Continue adjusting until fasting glucose reaches target without hypoglycemia 1

Important Considerations About This Regimen

The BID Lantus Issue

This patient's regimen is unusual and potentially problematic. Lantus (insulin glargine) is designed as a once-daily basal insulin with a relatively flat 24-hour action profile and no pronounced peak. 4, 5 Using it twice daily at such high doses (160 units total daily) suggests:

  • Possible overbasalization - using excessive basal insulin to compensate for inadequate mealtime coverage 1
  • The total basal dose of 160 units/day is extremely high and likely exceeds 0.5 units/kg for most patients 1

Signs of Overbasalization Present

Your patient demonstrates classic signs of overbasalization: 1

  • Hypoglycemia (morning lows)
  • Likely high bedtime-to-morning glucose differential
  • Excessively high basal insulin doses

Consider Regimen Restructuring

After Addressing Immediate Hypoglycemia

Once morning hypoglycemia is controlled, strongly consider converting to a more physiologic insulin regimen: 1

  1. Consolidate to once-daily Lantus (typically given at bedtime or morning, same time daily) 4, 5

    • Start with 80% of current total daily basal dose (128 units once daily) 1
    • This reduces overlapping insulin action that causes hypoglycemia 5, 3
  2. Intensify mealtime insulin coverage instead of relying on excessive basal insulin 1

    • Increase Humalog doses at meals using insulin-to-carbohydrate ratios 1
    • Add 4 units or 10% of basal dose to the largest meal initially 1
    • Titrate prandial doses by 1-2 units every 3 days based on post-meal glucose 1
  3. Alternative: Consider adding a GLP-1 RA before further intensifying insulin 1

    • This can improve postprandial control while reducing insulin requirements and hypoglycemia risk 1

Monitoring Requirements

  • Check fasting blood glucose daily during dose adjustments 1
  • Monitor for hypoglycemia symptoms, especially overnight 1, 5
  • Assess bedtime glucose to evaluate if it's dropping too much overnight 1
  • Review glucose patterns after 3-7 days before making further changes 1

Common Pitfalls to Avoid

  • Don't reduce both morning and evening doses simultaneously - this will cause daytime hyperglycemia 1
  • Don't ignore the underlying overbasalization - simply adjusting doses without addressing the regimen structure perpetuates the problem 1
  • Don't assume Lantus BID is optimal - while some patients benefit from twice-daily dosing, most achieve better control with once-daily administration 4, 5, 6
  • Don't forget to address mealtime coverage - sliding scale alone is inadequate for physiologic insulin replacement 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Insulin glargine (Lantus).

International journal of clinical practice, 2002

Research

Benefits of twice-daily injection with insulin glargine: a case report and review of the literature.

Tennessee medicine : journal of the Tennessee Medical Association, 2010

Related Questions

Should I adjust my Lantus (insulin glargine) dose from 64 units given a fasting blood sugar of 236?
Should I hold insulin glargine (long-acting insulin) when a patient decreases oral intake?
What adjustments should be made to a patient's insulin glargine (insulin glargine) regimen, currently 12 units in the morning and 10 units at bedtime, due to decreased oral and fluid intake?
What should be the Lantus (insulin glargine) dose, carbohydrate ratio, and correction scale for a 62-year-old female with a body mass index (BMI) of 28, weighing 68 kg, on Lantus 8 units at home and Novolog (insulin aspart) 12 units three times a day, who received dexamethasone (DEX) 8 mg and has poor oral intake?
What insulin dose adjustments are recommended for a 47-year-old type 2 diabetes patient on Lantus (insulin glargine) 55 units who will be NPO (nothing by mouth) at midnight and has undergone multiple tooth extractions?
What labs indicate inflammation?
What is the role of lactulose in managing acute liver failure with hepatic encephalopathy?
What is the best approach for managing the interaction between pantoprazole (proton pump inhibitor) and cabotegravir/rilpivirine (antiretroviral therapy) in a patient with HIV and gastroesophageal reflux disease?
What is the diagnosis and treatment approach for a patient with heart failure and a granular, sparkling appearance on echocardiogram (echo), with consideration of urine light chain analysis for cardiac amyloidosis?
What is the recommended treatment approach for a patient with a history of injection drug use and poor health status?
How to manage elevated blood pressure (hypertension) in patients with Parkinson's disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.